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INTRODUCTION
Among the various analytical methods using biochemistry or physio-
chemistry bioelectrochemistry is one of the most active and rapidly devel¬
oping fields. It is indeed rarely necessary to add any chemical in the
sample, thus allowing direct in vivo application of these methods, and
their selectivity and sensitivity is often sufficient to avoid any separ¬
ative or concentrative step. Besides the direct monitoring of a given
species and of its reacting properties analytical bioelectrochemistry is
also able to follow the heterogeous reactions occurring at a metal-solution
inter-face with biopolymers such as nucleic acids or proteins and evaluate
their conformation[1,2].
This introduction to the session devoted to electrochemistry in
biosciences is intended to present briefly the various methods used in
analytical bioelectrochemistry with a particular emphasis on in vivo
sensors (Table 1).
METAL-SOLUTION INTERFACE SENSORS
Non-destructive Methods: Use of Microelectrodes
The use of carbon or mercury micro-cathodes and platinum or carbon
micro-anodes enables the identification of a compound by the potential
necessary for its reduction or oxidation. It enables also the quanti¬
tative determination of such compounds using either limiting currents -
in steady-state methods - or peak currents - in transient method.
Detection limits reach ca 1 nM when background or capacitive currents are
filtered or compensated, in transient methods such as differential pulse
polarography (DPP) or voltammetry. Numerous redox molecules, either
metabolites or drugs, may be determined in biological samples either
directly or after an extraction procedure[3,4]. Particularly miniaturized
electrodes using carbon fibers or paste may be implanted and allow the
continuous monitoring of some metabolites and drugs in neuronal tissues or
arteries[5-8].
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Table 1. Main Characteristics of Bioelectrochemical Sensors
Sensor
type
Metal
electrode
Ion selective
electrode
(ISE)
Gas selective
electrode
(GSE)
Enzyme of
whole cell
electrode
Detected
species
Electroactive
(oxidant or
reducer)
Inorganic
ions
Electroactive
or acid-base
gases
Metabolites
inhibitors
Electro¬
chemical
detector
Metal + ref.
electrode
2 ref. electr.
IFSET + ref.
2 ref. electr.
metal + ref.
Metal + ref.
ISE, GSE
Membrane Without Glass
crystal
organic
Hydrophobic
polymer
permeable
to gas
Hydrophylic
polymer with
immobilized
enzyme or cells
Properties
of the
analyte
Electrochem.
reduction or
oxidation
Specific ionic
conductivity
of membrane
Gas diffusion
and redox or
acid-base
Enzyme or cell
catalyzed
reaction
Calibration
curve
I vs c
q vs c
E vs log c E vs log c
I vs c
I vs c
(dl/dt)max vs c
E vs log c
Response
type
Steady state
transient
Equilibrium Equilibrium
steady state
Steady state
transient
Destructive Methods: Coulometry
These methods, which to our knowledge are only used in vitro, enables
the determination of a compound by its complete oxidation or reduction on a
macroelectrode at a fixed potential or current: current is integrated till
the electrochemical detection of the final point. Coulometry may be either
direct if the analyte is electroactive, such as seric iron, or indirect:
the electrogenerated reagent may then be:
~t~ "H | |
- a complexing agent, such as Ag , Hg ££ Hg ^ ^ [
- a strong oxidant, such as bryip^ne, Ag , Mn or Au ,
- a strong reducer, such as Ti or viologen radical cations[9].
Because of their coulometric origin, if the end point is well det¬
ermined, all these methods are absolute and do not need any calibration.
Some clinical instruments, such as blood chloride meters, use such Ag
generated coulometries.
An alternative to these method was originally proposed by Bruckenstein
and Albery[10-12] and used with biological species or samples by Rauwell
and Thévenot[13-15]: with a rotating ring-disk electrode a reactant is
electrogenerated on the disk, reacts with the analyte in the vicinity of
the electrode and its excess is eventually detected on the ring. When
titration reaction is rapid enough, detection limit of this non-destructive
alternative to indirect coulometry reaches 100 nM.
Another alternative to, or more precisely, application of in vivo
coulometry has recently been proposed by Albery for long term implanted
carbon electrodes: a controlled electrolysis on a brain microelectrode
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surrounded by living cells allows the oxidation of ascorbate and thus its
elimination in a further anodic voltammogram: it is therefore possible to
detect much lower concentration of neurotransmitters or of their metabol¬
ites and study the effect of chronic drug treatment[5,8,16].
ION SELECTIVE ELECTRODES (ISE)
Glass, crystalline and organic membranes which present specific ionic
conductivity have been intensively used for direct determination of ion
activity. Measurement of membrane potentials using either 2 reference
electrodes such as Ag/AgCl, CI- or Hg/Hg2C12, CI- [17-19] or a field effect
transistor (ISFET) and a reference electrode[20] allows the determination
of ion activities. Most of the present studies involve the preparation and
characterization of organic membranes impregnated with water insoluble
compounds specifically chelating some ions.
Such ISE are being progressively introduced into clinical laboratories
for hydrogen, sodium, potassium and calcium ion determination[21,22].
Miniaturized models have been developed for in vivo intra-tissue or intra¬
cellular ion determinations[23-27] and for the detection of foetal suffer¬
ing during delivery by detecting a slight pH decrease in the scale tis¬
sue [ 28] .
GAS SELECTIVE ELECTRODES (GSE)
Some gases may be selectively detected: they need to be either elec-
troactive (oxygen, bromine) or acido-basic (carbon dioxide, sulfhydric
acid, ammonia) and diffuse through an hydrophobic membrane (teflon,
polyethylene). Thus such GSE are generally built with a metal or a pH
electrode covered with a gas permeable membrane[17,18,29,30].
Very frequently used in analytical laboratories, GSE have been intro¬
duced into clinical laboratories in the last few years for the direct
determination of blood gases on very small samples[31] and for intravas¬
cular monitoring of oxygen, tension of blood[32,34]. Non-invasive trans¬
cutaneous oxygen or carbon dioxide electrodes may alternatively be placed
on the surface of the heated skin of neonates or adults: the electrode
response is directly proportional to arterial oxygen and carbon dioxide
tensions[34-38].
ENZYME OR CELL ELECTRODES
This last type of specific electrode is certainly the most versatile
but also, and this is often ignored, the most complex one. One or several
enzymes are immobilized on a membrane by entrapment, adsorption, coreticul-
ation or covalent coupling[39-41]. Alternatively bacterial or vegetal
whole cells are entrapped or fixed on a membrane[41,42]. When such mem¬
brane are placed in class vicinity to an appropriate electrochemical
detector, it is possible to associate the extremely selective properties of
enzymes and the versatility of the previously mentioned electrochemical
sensors. Indeed several tens of such electrodes have been described in the
literature for the determination of either metabolites (enzyme or cell
substrates) or toxic compounds (enzyme inhibitors); more recently, immuno-
enzymatic electrodes have been described using immobilized enzymes coupled
to antibodies.
Since the pioneer work of Clark in 1962[43], several hundred publi¬
cations and several international meetings have been devoted to enzyme
electrodes and especially to glucose sensors[39,40). However very few
instruments are commercially available besides the glucose sensor com-
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mercialized for several years by Yellow Spring Instrument. One may find in
France glucose sensors made by Solea Tacussel and Seres and a lactate
sensor made by Setric; these enzyme electrodes are respectively based upon
the previous research activity of Thévenot, Coulet and Gautheron[44,45] and
Romette and Thomas[46] and of Durliat and Comtat[47]. Such a small number
of commercially available sensors and instruments is mainly related to the
complexity of the heterogeneous kinetics and thermodynamics involved in
these sensors, but also to the usually poor characterization of the mem¬
brane and sensing head and to the absence of theory taking into account the
numerous experimental parameters.
The major interest and possibilities of such sensors for clinical,
fermentation control and food industry control and on-line analysis have
led several research groups to spend time and effort for a better under¬
standing of enzyme electrodes. This effort is even more important for in
vivo devices and especially for the glucose sensing part of an artificial
pancreas[40]: extra-corporal closed-loop devices have for example been
developed and tested on animals by Abel in Karlsburg [48,49], whereas
needle-type glucose sensors have been presented by Shichiri[50,51]. Both
devices include multimembrane systems for enzyme entrapment, glucose and
oxygen flux regulation, and protection from blood clotting. For such in
vivo glucose sensors it is indeed necessary to solve several specific
problems simultaneously.
- glucose concentration is usually much larger in blood than the
Michaelis constant for glucose oxidase,
- oxygen concentration is different in blood and in air-saturated
solution and may vary upon ventilation,
- hydrodynamical conditions, i.e. blood velocity in the sensor vicinity,
may vary or be poorly controlled especially if the glucose sensor is
implanted subcutaneously,
- response time should be smaller than 2-5 min for a good insulin
regulation,
- glucose oxidase being normally absent from blood should not be
released by the sensor.
In collaboration with Reach from the Faculté Villemin of the Paris
University, we have studied these problems using an extra-corporal blood
circulation in a conscious freely-moving rat (Figure 1). Preliminary
results obtained during intravenous glucose tolerance test (IVGTT) have
given interesting results when an in vivo calibration was performed and
when the delay period of our device, i.e. response time + circulation time,
was taken into account (Figure 2 and 3). Studies are in progress in order
to compare results obtained with different enzymatic membranes and to
characterize the most important parameters (permeabilities, partition
coefficients, enzyme load and activity) of such membranes.
CONCLUSION
This rapid survey of present possibilities of analytical bioelectro-
chemistry shows that the following research fields are particularly active:
a) ultra-microelectrodes implanted in neuronal tissues, intravascularly
or subcutaneously in order to monitor continuously in vivo electro-
active species, ions or metabolites,
b) development of ISE or ISFET using organic ion conducting membranes and
studying alternatives to the external reference electrode,
c) specific electrodes using either immobilized enzymes or whole cells in
which the vessel and electrode design is optimized for a given applic¬
ation,
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Fig. 1. Schematic diagram of in vivo evaluation of glucose sensor on
conscious freely-moving rat.
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Fig. 2. Intravenous glucose tolerance test (IVGTT) on a sensor connected
to a conscious freely-moving rat. (...) direct signal from
glucose sensor using a glucose oxidase cellulose acetate membrane,
(o) reference values using a Beckman glucometer.
d) and finally, development of modern instrumentation using autocalibra-
tion and control procedures associated with signal processing and
interpretation. This latter field is of great importance in clinical
applications.
The following paper, presented by Wightman, gives a more detailed
review on implanted ultramicroelectrodes especially developed for neuronal
tissue. The continuous monitoring of neurotransmitters and their metabol¬
ites is indeed one of the present challenges of analytical bioelectro-
chemistry.
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Fig. 3. Comparison of glucose values obtained with in vivo calibration
before IVGTT and reference values using Beckman glucometer. A
4.5 min time-lag of the sensor, including 3.0 min response time
and 1.5 min external circulation time has been taken into account
for this comparison. Figures refer to blood samples identifi¬
cation numbers plotted on Figure 2.
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